Biogen
BIIB
#864
Rank
NZ$46.29 B
Marketcap
NZ$315.57
Share price
0.68%
Change (1 day)
14.86%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Cost to borrow BIIB shares - Biogen

Latest borrow fee for Biogen (BIIB) shares on Interactive Brokers: 0.4081% (annualized)

Shares available to borrow: 3100000

The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

Biogen (BIIB) - cost to borrow in the last 7 days chart

Biogen (BIIB) - number of shares available to borrow in the last 7 days

Biogen (BIIB) - cost to borrow from 2025 to 2023

Biogen (BIIB) - number of shares available to borrow from 2025 to 2023

Cost to borrow for shares of similar companies or competitors

Company Cost to borrow (% year) Shares available Country
Amgen
AMGN
0.25%5.1 M๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
0.4081%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
0.25%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
0.2543%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
0.25%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
64.8578%0 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
0.4081%2 M๐Ÿ‡ซ๐Ÿ‡ท France
Bio-Rad Laboratories
BIO
0.2891%0.15 M๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
0.266%3.5 M๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
0.4172%0.2 M๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands